Table of Contents
The president and CEO of Novavax, Stanley C. Erck’s net worth establishes him as a multi-millionaire.
Stanley C. Erck is the president, CEO, and director of the American vaccine development company called Novavax Inc. The businessman has been serving the position since 2011.
The company mainly focuses on discovering new medicines and further developing already known medicines. Stanley earns a massive amount from the company and is a multi-millionaire. Continue to know about his actual net worth facts and salary.
Quick Facts:
| Name | Stanley Erck |
| Age | 72 |
| Gender | Male |
| Height | – |
| Nationality | American |
| Profession | President, CEO |
| Net Worth | $14.5 Million |
| Salary | $2.438 Million (Annual) |
| Education | University of Chicago |
Novavax shares are soaring after announcing it has begun human testing for a COVID-19 vaccine.
CEO Stanley Erck joined us exclusively to discuss the company’s latest results.@CNBC @carlquintanilla @morganlbrennan @jonfortt @megtirrell $NVAX pic.twitter.com/EVjMvrIY4H
— Squawk Alley (@SquawkAlley) May 26, 2020
Stanley C. Erck Salary And Net Worth
The President and CEO of Novavax, Stanley C. Erck’s net worth is estimated to be at least $14.5 million as per Wallmine.
The 72-year-old Stanley’s main source of wealth is the shares held by him. Stanley currently holds 52317 unit shares of Novavax which values more than $8.45 million. Other than that, his properties and belongings also add up to a significant portion of his net worth.
Likewise, talking about Stanley C. Erck’s salary, he earns an incredible $2.438 million annually from the company. He is considered one of the highest-paid executives in the company.
Stanley C. Erck Wife, Wikipedia, And Family
Regarding his married life, there is no information about Stanley C. Erck’s wife and children.
The American business has been able to keep his personal life very secret and far from media attention. That is why we do not have any information regarding his family life.
Similarly, despite being able to make headlines regularly, Stanley C. Erck’s Wikipedia bio has not been published yet. However, there is a Wikipedia about the Company Novavax which is among the candidates in developing the vaccine against the COVID-19 virus.
“The results of this vaccine are better than anyone expected.” said $NVAX CEO Stanley C. Erck. $493.16 gets NVAX to the same market cap as $MRNA. #stocks #investing #vaccine #covid19 #StayAtHomeSaveLives https://t.co/iC4ieNPg0q
— Aaron Spencer (@foing) August 4, 2020
Stanley C. Erck Social Media and Career
Talking about his social media presence, Stanley cannot be found on any social media sites. He seems to very away from social media discussions.
Likewise, winding up the article with his career highlights, he previously worked as President and CEO of Iomai Corporation. Similarly, he also led some other companies before joining Novavax. Some of them are Procept, Integrated Genetics (now Sanofi Genzyme), and Baxtor International.
,